Stay up-to-date with all of the life science events taking place in the Greater Boston area with the Science in Boston events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Boston. We even cover science pub nights and science fundraisers!

If you’re interested in promoting your life science event on the Science in Boston events calendar, please use our event submission form.

Loading Events

« All Events

  • This event has passed.

Webinar: Impact of SARS-CoV-2 Infection on the Central Nervous System

August 5, 2020

Event Navigation


Infectious Disease Webinar Series

With a global effort underway to find prophylactic and therapeutic options to combat the COVID-19 pandemic, more information is becoming available on the pathogenesis of SARS-CoV-2 and the associated immune response. However, significant gaps remain in our understanding of the impact of SARS-CoV-2 on the central nervous system. In this presentation, part of our Infectious Disease Webinar Series, Eric Song will highlight advances in this field and discuss the neuro-invasive potential and neuroinflammatory implications of SARS-CoV-2 infection.

Join us for this presentation followed by a live Q&A session. Register now and submit your questions in advance for the speaker to answer during the Q&A session.

Eric Song, MD/PhD Candidate
Yale University
Live Webinar: Exploring the Impact of SARS-CoV-2 Infection on the Central Nervous SystemWednesday August 5, 2020 | 9:00 a.m. PDT | 12:00 p.m. EDT | 4:00 p.m. UTC

If you are unable to attend the live webinar, please register and you will receive a link for the recording.

Eric Song is an MD/PhD candidate in Dr. Akiko Iwasaki’s lab at Yale University. His work in the field of neuroimmunology focuses on finding ways to prime the immune system against brain tumors, and his recent preprint publications are focused on the impact of SARS-CoV-2 on the central nervous system.




STEMCELL Technologies
+1 604 877 0713